Systematic review of case reports of Japanese esophageal neuroendocrine cell carcinoma in the Japanese literature-Reference-Cited by-同舟云学术

Systematic review of case reports of Japanese esophageal neuroendocrine cell carcinoma in the Japanese literature

Published:2019-02-18 Issue:2 Volume:8 Page:47-57
ISSN:2192-3183
Container-title:International Cancer Conference Journal
language:en
Short-container-title:Int Canc Conf J

Author:

Kikuchi Yoshinori,Shimada Hideaki^ORCID,Yamaguchi Kazuhisa,Igarashi Yoshinori

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/article/10.1007/s13691-019-00359-5/fulltext.html

Reference161 articles.

1. McKeown F (1952) Oat cell carcinoma of the esophagus. J Pathol Bacteriol 64:889–891

2. Chino O, Makuuch H, Ozawa S et al (2017) Endoscopic diagnosis of the esophageal neuroendocrine cell carcinoma: its morphological and histopathological features and clinical problems. Stomach Intest 52:402–411. (in Japanese)

3. Japan Esophageal Society (2014) Guidelines for diagnosis and treatment of carcinoma of the esophagus. Kanehara, Tokyo (Japanese)

4. Tustumi F, Takeda FR, Uema RH et al (2017) Primary neuroendocrine neoplasm of the esophagus—report of 14 cases from a single institute and review of the literature. Arq Gastroenterol 54:4–10

5. Deng H-Y, Ni P-Z, Wang Y-C et al (2016) Neuroendocrine carcinoma of the esophagus: clinical characteristics and prognostic evaluation of 49 cases with surgical resection. J Thorac Dis 8:1250–1256

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rare malignant neoplasm of the esophagus: current status and future perspectives;Japanese Journal of Clinical Oncology;2023-10-19

2. Anlotinib plus camrelizumab achieved long‐term survival in a patient with metastatic esophageal neuroendocrine carcinoma;Cancer Reports;2023-06-28

3. Strahlentherapie endokriner Tumoren;Die Onkologie;2022-07-09

4. A case of endoscopic submucosal dissection for neuroendocrine carcinoma of the esophagus with invasion to the muscularis mucosae;Clinical Journal of Gastroenterology;2022-01-24

5. Salvage camrelizumab plus apatinib for relapsed esophageal neuroendocrine carcinoma after esophagectomy: a case report and review of the literature;Cancer Biology & Therapy;2020-10-23